Dynorphin A (1-13) H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-OH
| Title | Journal |
|---|---|
| Controlling charge states of peptides through inductive electrospray ionization mass spectrometry. | Analytical chemistry 20111201 |
| Oxytocin in the periaqueductal gray participates in pain modulation in the rat by influencing endogenous opiate peptides. | Peptides 20110601 |
| Morphine-induced conditioned place preference in rats is inhibited by electroacupuncture at 2 Hz: role of enkephalin in the nucleus accumbens. | Neuropharmacology 20100101 |
| Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa. | Peptides 20081201 |
| Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2. | Journal of medicinal chemistry 20080410 |
| Central reinforcing effects of ethanol are blocked by catalase inhibition. | Alcohol (Fayetteville, N.Y.) 20071101 |
| Influence of acute and chronic treadmill exercise on rat plasma lactate and brain NPY, L-ENK, DYN A1-13. | Cellular and molecular neurobiology 20070201 |
| Conformational analysis of dynorphin A (1-13) using hydrogen-deuterium exchange and tandem mass spectrometry. | European journal of mass spectrometry (Chichester, England) 20070101 |
| Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats. | Life sciences 20060418 |
| Through central arginine vasopressin, not oxytocin and endogenous opiate peptides, glutamate sodium induces hypothalamic paraventricular nucleus enhancing acupuncture analgesia in the rat. | Neuroscience research 20060101 |
| A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgia. | Journal of opioid management 20060101 |
| New tris-alkoxycarbonyl arginine derivatives for peptide synthesis. | Journal of peptide science : an official publication of the European Peptide Society 20050101 |
| Metabolism of dynorphin A(1-13). | Die Pharmazie 20040501 |
| Aggression and the three opioid families (endorphins, enkephalins, and dynorphins) in mice. | Behavior genetics 20030901 |
| Dynorphin and the hypothalamo-pituitary-adrenal axis during fetal development. | Life sciences 20030627 |
| [Changes of dynorphinA1-13 on the treatment of hypoxic-ischemic brain injury by the brain-derived neurotrophic factor in neonatal rats]. | Zhonghua yi xue za zhi 20021210 |
| Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects. | Journal of neurophysiology 20020301 |
| [Effect of opioid peptides on the repair regeneration of the bone tissue]. | Arkhiv patologii 20020101 |
| Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. | The Journal of pharmacology and experimental therapeutics 19990401 |
| Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. | The Journal of pharmacology and experimental therapeutics 19990101 |
| Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. | British journal of pharmacology 19971001 |
| Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice. | European journal of pharmacology 19950214 |
| Dynorphin A (1-13) in the brain suppresses epinephrine-induced ventricular premature complexes and ventricular tachyarrhythmias. | Regulatory peptides 19920922 |
| [The role of the opiate mechanisms of the hippocampus and substantia nigra in the behavioral and convulsive disorders in picrotoxin-induced kindling]. | Biulleten' eksperimental'noi biologii i meditsiny 19910301 |
| Effects of dynorphin A(1-13) and of fragments of beta-endorphin on blood pressure and heart rate of anesthetized rats. | Canadian journal of physiology and pharmacology 19910301 |
| Possible involvement of beta endorphin(1-31) and dynorphin(1-13) in the central hypotensive mechanism of action of alpha methyldopa. | Neuroendocrinology 19890101 |
| Cardiovascular effects of dynorphin A (1-13) in conscious rats and its modulation of morphine bradycardia over time. | Peptides 19870101 |
| Sensitivity to morphine-evoked bradycardia in rats is modified by dynorphin (1-13), Leu- and Met-enkephalin. | The Journal of pharmacology and experimental therapeutics 19840501 |
| Effect of dynorphin-(1-13) and related peptides on respiratory rate and morphine-induced respiratory rate depression. | European journal of pharmacology 19831209 |